HOME >> MEDICINE >> NEWS
Vaccine Against Melanoma Proves Successful For Patients With Disease Spread To Two Lymph Node Areas

A custom-made vaccine created from a patient's own cancer tumor cells appears effective in prolonging the survival of patients with malignant melanoma, the deadliest form of the skin cancer, spread to two lymph node areas.

David Berd, professor of medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia and a member of Jefferson's Kimmel Cancer Center, and his colleagues had previously proven the effectiveness of the vaccine in treating patients with malignant melanoma. Now, the researchers treated a subset of the original group of patients who had a particularly poor prognosis. Each had cancer that had spread to two lymph node areas, and each had surgery to remove the visible disease. The patients were then given the vaccine. According to Dr. Berd, 39 percent are estimated to live three years. In general, he says, only some 5 to 15 percent of such patients are cured by surgery alone.

In 15 patients with melanoma spread to the pelvic lymph nodes, 47 percent are estimated to live five-years. The usual surgical cure rate is only 5 to 10 percent.

"Now we're looking at a group of patients with a particularly bad prognosis, and our results strengthen the evidence that the vaccine is therapeutic in a critical situation," says Dr. Berd.

He reports his results April 13 at the American Association for Cancer Research meeting in Philadelphia.

The vaccine is termed autologous, meaning that it's prepared from a patient's own cancer cells. Before injecting the cells into patients, the cells are inactivated and treated with a chemical, dinitrophenyl (DNP), which chemically modifies them. The modified cells appear foreign enough to the body's immune system for it to react against them.

In the June 1997 issue of the Journal of Clinical Oncology, Dr. Berd reported the results of treatments on patients with melanoma spread to a single lymph node site (stage III disease).
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
13-Apr-1999


Page: 1 2

Related medicine news :

1. Vaccine against childhood pneumonia shows promise
2. Vaccine may complement conventional treatment for chronic leukaemia
3. Vaccine preparedness, or not
4. Oct. 14 Web cast: Reporters Workshop -- Covering Vaccines & Immunizations
5. Vaccine reduces racial disparity in incidence of childhood pneumonia and meningitis
6. Vaccine nips breast cancer in the bud
7. Vaccine shows promise for kidney cancer
8. Vaccine development against influenza A (h5n1) virus should be made a priority
9. Vaccines against fatal African cattle fever
10. Vaccine development sparks debate on changes to cervical cancer screening guidelines
11. Vaccine shortage study exposes nations patchwork system

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2019)... ... June 20, 2019 , ... SightMD (or the ... Founders, announced a strategic partnership with Northern Westchester Ophthalmology, P.C. (“NWO”) and its ... in New York, adding the Company’s first location in Westchester County to SightMD’s ...
(Date:6/19/2019)... ... 19, 2019 , ... The number of public health departments ... of performance continues to climb. Today, the Public Health Accreditation Board ... public health departments. With this week's accreditation decisions, tens of thousands more people ...
(Date:6/19/2019)... ... June 19, 2019 , ... The ... Congress (IRC) in Marseille, France. The conference is widely seen as the ... muscular dystrophy (FSHD). Nearly 200 researchers, clinicians, industry representatives and patient advocates are ...
(Date:6/18/2019)... ... June 18, 2019 , ... EMulate Therapeutics, Inc. ... serious diseases, announced it has received notice that the US Food and Drug ... (HDE) for the Hælo Pediatric system. The FDA granted the Humanitarian Use ...
(Date:6/18/2019)... ST. LOUIS (PRWEB) , ... June 18, 2019 ... ... cost, quality and clinical outcomes, today announced Steve Einig has joined the organization ... will lead strategy and corporate initiatives around market engagement, marketing, strategic events and ...
Breaking Medicine News(10 mins):
(Date:6/20/2019)... ... June 20, 2019 , ... Phlexglobal today announced an important industry advisory around ... effect on June 6, 2019, and promises to have far-reaching impacts on an organization’s ... , At 17 pages and going into specific detail – unusual for most guidance ...
(Date:6/19/2019)... ... June 19, 2019 , ... Mahendra Kumar ... Thermal and Physical Properties of Biofield Treated Bile Salt and Proteose Peptone became ... Biophysics, Preventive Medicine, Biochemistry, Medical Technology, Pathophysiology, Molecular Biology, Science Reference and 45-Minute ...
(Date:6/19/2019)... SAN LUIS OBISPO, Calif. (PRWEB) , ... June 19, 2019 , ... “We sometimes take ... daily brushing and flossing, and regular checkups we seldom think about our teeth unless it’s ... , Our teeth help us chew, speak, smile and have a very important role in ...
Breaking Medicine Technology:
Cached News: